Reverse translational strategies for developing animal models of bipolar disorder

DMM Disease Models and Mechanisms

Volumn 2, Issue 5-6, 2009, Pages 238-245

  Malkesman, Oz ^a   Austin, Daniel R ^a   Chen, Guang ^a   Manji, Husseini K ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; GLUTAMATE RECEPTOR 6; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2;

B CELL LYMPHOMA; BIPOLAR DISORDER; DEPRESSION; GENE EXPRESSION; MANIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; DISEASE MODEL; DISEASE PREDISPOSITION; GENETICS; HUMAN; MUTATION; PATHOLOGY;

ANIMALIA;

ANIMALS; BIPOLAR DISORDER; DEPRESSION; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; HUMANS; MUTATION;

EID: 67650311660     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.001628     Document Type: Review

References (105)

1. Antelman, S. M., Caggiula, A. R., Kucinski, B. J., Fowler, H., Gershon, S., Edwards, D. J., Austin, M. C., Stiller, R., Kiss, S. and Kocan, D. (1998). The effects of lithium on a potential cycling model of bipolar disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 22, 495-510. (Pubitemid 28206652)
2. Ayensu, W. K., Pucilowski, O., Mason, G. A., Overstreet, D. H., Rezvani, A. H. and Janowsky, D. S. (1995). Effects of chronic mild stress on serum complement activity, saccharin preference, and corticosterone levels in Flinders lines of rats. Physiol. Behav. 57, 165-169.
3. Bachmann, R. F., Wang, Y., Yuan, P., Zhou, R., Li, X., Alesci, S., Du, J. and Manji, H. K. (2009). Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage. Int. J. Neuropsychopharmacol. Jan 19, 1-18.
4. Bai, O., Zhang, H. and Li, X. M. (2004). Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus. Brain Res. 1010, 81-86. (Pubitemid 38569855)
5. Belke, T. W. (1997). Running and responding reinforced by the opportunity to run: effect of reinforcer duration. J. Exp. Anal. Behav. 67, 337-351. (Pubitemid 127460401)
6. Belmaker, R. H. (2004). Bipolar disorder. N. Engl. J. Med. 351, 476-486.
7. Benes, F. M., Lim, B., Matzilevich, D., Walsh, J. P., Subburaju, S. and Minns, M. (2007). Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc. Natl. Acad. Sci. USA 104, 10164-10169. (Pubitemid 47175280)
8. Beneyto, M., Kristiansen, L. V., Oni-Orisan, A., McCullumsmith, R. E. and Meador- Woodruff, J. H. (2007). Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology 32, 1888-1902.
9. Berridge, C. W. and Stalnaker, T. A. (2002). Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex. Synapse 46, 140-149. (Pubitemid 35155167)
10. Binder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Putz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A. et al. (2004). Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat. Genet. 36, 1319-1325. (Pubitemid 39577942)
11. Binder, E. B., Bradle, R. G., Liu, W., Epstein, M. P., Deveau, T. C., Mercer, K. B., Tang, Y., Gillespie, C. F., Heim, C. M., Nemeroff, C. B. et al. (2008). Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 299, 1291-1305.
12. Boivin, D. B. (2000). Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders. J. Psychiatry Neurosci. 25, 446-458.
13. Borison, R. L., Sabelli, H. C., Maple, P. J., Havdala, H. S. and Diamond, B. I. (1978). Lithium prevention of amphetamine-induced 'manic' excitement and of reserpineinduced 'depression' in mice: possible role of 2-phenylethylamine. Psychopharmacology (Berl.) 59, 259-262.
14. Bunney, W. E. and Bunney, B. G. (2000). Molecular clock genes in man and lower animals: possible implications for circadian abnormalities in depression. Neuropsychopharmacology 22, 335-345.
15. Chang, H. Y., Grygoruk, A., Brooks, E. S., Ackerson, L. C., Maidment, N. T., Bainton, R. J. and Krantz, D. E. (2006). Overexpression of the Drosophila vesicular monoamine transporter increases motor activity and courtship but decreases the behavioral response to cocaine. Mol. Psychiatry 11, 99-113. (Pubitemid 43251092)
16. Chen, D. F., Schneider, G. E., Martinou, J. C. and Tonegawa, S. (1997). Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 385, 434-439.
17. Chen, G. and Manji, H. K. (2006). The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers. Curr. Opin. Psychiatry 19, 313-323. (Pubitemid 44309491)
18. Chen, G., Zeng, W. Z., Yuan, P. X., Huang, L. D., Jiang, Y. M., Zhao, Z. H. and Manji, H. K. (1999). The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J. Neurochem. 72, 879-882. (Pubitemid 29055256)
19. Chuang, D. M. (2004). Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases? Crit. Rev. Neurobiol. 16, 83-90.
20. Chuang, D. M. (2005). The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. Ann. NY Acad. Sci. 1053, 195-204.
21. Coyle, J. T. and Duman, R. S. (2003). Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38, 157-160.
22. Cryan, J. F. and Holmes, A. (2005). The ascent of mouse: advances in modelling human depression and anxiety. Nat. Rev. Drug Discov. 4, 775-790.
23. Csaba, G. and Karabelyos, C. (2001). The effect of a single neonatal treatment (hormonal imprinting) with the antihormones, tamoxifen and mifepristone on the sexual behavior of adult rats. Pharmacol. Res. 43, 531-534. (Pubitemid 32619988)
24. Dick, D. M., Foroud, T., Flury, L., Bowman, E. S., Miller, M. J., Rau, N. L., Moe, P. R., Samavedy, N., El-Mallakh, R., Manji, H. et al. (2003). Genomewide linkage analyses of bipolar disorder: a new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative. Am. J. Hum. Genet. 73, 107-114. (Pubitemid 36793784)
25. Einat, H. (2007). Different behaviors and different strains: potential new ways to model bipolar disorder. Neurosci. Biobehav. Rev. 31, 850-857.
26. Einat, H. and Manji, H. K. (2006). Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder. Biol. Psychiatry 59, 1160-1171. (Pubitemid 43949143)
27. Einat, H., Yuan, P. and Manji, H. K. (2005). Increased anxiety-like behaviors and mitochondrial dysfunction in mice with targeted mutation of the Bcl-2 gene: further support for the involvement of mitochondrial function in anxiety disorders. Behav. Brain Res. 165, 172-180. (Pubitemid 41568576)
28. Einat, H., Kronfeld-Schor, N. and Eilam, D. (2006). Sand rats see the light: short photoperiod induces a depression-like response in a diurnal rodent. Behav. Brain Res. 173, 153-157. (Pubitemid 44572021)
29. Engel, S. R., Creson, T. K., Hao, Y., Shen, Y., Maeng, S., Nekrasova, T., Landreth, G. E., Manji, H. K. and Chen, G. (2008). The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement. Mol. Psychiatry 14, 448-461.
30. Ferreira, M. A., O'Donovan, M. C., Meng, Y. A., Jones, I. R., Ruderfer, D. M., Jones, L., Fan, J., Kirov, G., Perlis, R. H., Green, E. K. et al. (2008). Collaborative genomewide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat. Genet. 40, 1056-1058.
31. Fukui, M., Rodriguiz, R. M., Zhou, J., Jiang, S. X., Phillips, L. E., Caron, M. G. and Wetsel, W. C. (2007). Vmat2 heterozygous mutant mice display a depressive-like phenotype. J. Neurosci. 27, 10520-10529. (Pubitemid 47502010)
32. Gessa, G. L., Pani, L., Fadda, P. and Fratta, W. (1995). Sleep deprivation in the rat: an animal model of mania. Eur. Neuropsychopharmacol. 5 Suppl, 89-93. (Pubitemid 26017265)
33. Goodwin, F. K. and Jamison, K. R. (2007). Manic-Depressive Illness. New York: Oxford University Press.
34. Gould, T. D. and Gottesman, I. I. (2006). Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behav. 5, 113-119. (Pubitemid 43344963)
35. Gould, T. D. and Einat, H. (2007). Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement. Neurosci. Biobehav. Rev. 31, 825-831.
36. Gould, T. D., Chen, G. and Manji, H. K. (2004a). In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Neuropsychopharmacology 29, 32-38.
37. Gould, T. D., Einat, H., Bhat, R. and Manji, H. K. (2004b). AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int. J. Neuropsychopharmacol. 7, 387-390. (Pubitemid 39648068)
38. Gould, T. D., Einat, H., O'Donnell, K. C., Picchini, A. M., Schloesser, R. J. and Manji, H. K. (2007). Beta-catenin overexpression in the mouse brain phenocopies lithiumsensitive behaviors. Neuropsychopharmacology 32, 2173-2183. (Pubitemid 47417687)
39. Hao, Y., Creson, T., Zhang, L., Li, P., Du, F., Yuan, P., Gould, T. D., Manji, H. K. and Chen, G. (2004). Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J. Neurosci. 24, 6590-6599. (Pubitemid 38971708)
40. Hayden, E. P. and Nurnberger, J. I., Jr (2006). Molecular genetics of bipolar disorder. Genes Brain Behav. 5, 85-95.
41. Himmelsbach, C. K., Gerlach, G. H. and Stanton, E. J. (1935). A method for testing addiction, tolerance and abstinence in the rat: results of its application to several morphine alkaloids. J. Phamacol. Exp. Ther. 53, 179-188.
42. Huang, E. J. and Reichardt, L. F. (2003). Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 72, 609-642. (Pubitemid 36930455)
43. Huang, Y. Y., Peng, C. H., Yang, Y. P., Wu, C. C., Hsu, W. M., Wang, H. J., Chan, K. H., Chou, Y. P., Chen, S. J. and Chang, Y. L. (2007). Desipramine activated Bcl-2 expression and inhibited lipopolysaccharide-induced apoptosis in hippocampusderived adult neural stem cells. J. Pharmacol. Sci. 104, 61-72.
44. Humby, T., Laird, F. M., Davies, W. and Wilkinson, L. S. (1999). Visuospatial attentional functioning in mice: interactions between cholinergic manipulations and genotype. Eur. J. Neurosci. 11, 2813-2823. (Pubitemid 29364198)
45. Hunter, A. J., Hatcher, J., Virley, D., Nelson, P., Irving, E., Hadingham, S. J. and Parsons, A. A. (2000). Functional assessments in mice and rats after focal stroke. Neuropharmacology 39, 806-816. (Pubitemid 30103684)
46. Insel, T. R. (2007). From animal models to model animals. Biol. Psychiatry 62, 1337-1339.
47. Ishizuka, K., Paek, M., Kamiya, A. and Sawa, A. (2006). A review of Disrupted-In-Schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions. Biol. Psychiatry 59, 1189-1197. (Pubitemid 43912556)
48. Iwamoto, K., Bundo, M. and Kato, T. (2005). Altered expression of mitochondriarelated genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum. Mol. Genet. 14, 241-253.
49. Jones, S. H. (2001). Circadian rhythms, multilevel models of emotion and bipolar disorder-an initial step towards integration? Clin. Psychol. Rev. 21, 1193-1209.
50. Kaidanovich-Beilin, O., Milman, A., Weizman, A., Pick, C. G. and Eldar-Finkelman, H. (2004). Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. Biol. Psychiatry 55, 781-784. (Pubitemid 38429867)
51. Kasahara, T., Kubota, M., Miyauchi, T., Noda, Y., Mouri, A., Nabeshima, T. and Kato, T. (2006). Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes. Mol. Psychiatry 11, 577-593, 523.
52. Kato, T. and Kato, N. (2000). Mitochondrial dysfunction in bipolar disorder. Bipolar Disord. 2, 180-190.
53. Kato, T., Stine, O. C., McMahon, F. J. and Crowe, R. R. (1997). Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder. Biol. Psychiatry 42, 871-875. (Pubitemid 27486439)
54. Kato, T., Kunugi, H., Nanko, S. and Kato, N. (2001). Mitochondrial DNA polymorphisms in bipolar disorder. J. Affect. Disord. 62, 151-164. (Pubitemid 32167082)
55. Kato, T., Kubota, M. and Kasahara, T. (2007). Animal models of bipolar disorder. Neurosci. Biobehav. Rev. 31, 832-842.
56. Klein, P. S. and Melton, D. A. (1996). A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA 93, 8455-8459.
57. Klemfuss, H. (1992). Rhythms and the pharmacology of lithium. Pharmacol. Theory 56, 53-78.
58. Konradi, C., Eaton, M., MacDonald, M. L., Walsh, J., Benes, F. M. and Heckers, S. (2004). Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch. Gen. Psychiatry 61, 300-308. (Pubitemid 38295832)
59. Kuhn, H. G., Biebl, M., Wilhelm, D., Li, M., Friedlander, R. M. and Winkler, J. (2005). Increased generation of granule cells in adult Bcl-2-overexpressing mice: a role for cell death during continued hippocampal neurogenesis. Eur. J. Neurosci. 22, 1907-1915. (Pubitemid 41579381)
60. Laje, G., Paddock, S., Manji, H., Rush, A. J., Wilson, A. F., Charney, D. and McMahon, F. J. (2007). Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. Am. J. Psychiatry 164, 1530-1538. (Pubitemid 350069732)
61. Lekman, M., Laje, G., Charney, D., Rush, A. J., Wilson, A. F., Sorant, A. J., Lipsky, R., Wisniewski, S. R., Manji, H., McMahon, F. J. et al. (2008). The FKBP5-gene in depression and treatment response-an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) cohort. Biol. Psychiatry 63, 1103-1110.
62. Lien, R., Flaisher-Grinberg, S., Cleary, C., Hejny, M. and Einat, H. (2008). Behavioral effects of Bcl-2 deficiency: implications for affective disorders. Pharmacol. Rep. 60, 490-498.
63. Luo, C., Xu, H. and Li, X. M. (2004). Post-stress changes in BDNF and Bcl-2 immunoreactivities in hippocampal neurons: effect of chronic administration of olanzapine. Brain Res. 1025, 194-202. (Pubitemid 39349538)
64. Machado-Vieira, R., Kapczinski, F. and Soares, J. C. (2004). Perspectives for the development of animal models of bipolar disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 28, 209-224. (Pubitemid 38130126)
65. Maeda, K., Nwulia, E., Chang, J., Balkissoon, R., Ishizuka, K., Chen, H., Zandi, P., McInnis, M. G. and Sawa, A. (2006). Differential expression of disrupted-inschizophrenia (DISC1) in bipolar disorder. Biol. Psychiatry 60, 929-935. (Pubitemid 44584211)
66. Maeng, S., Hunsberger, J. G., Pearson, B., Yuan, P., Wang, Y., Wei, Y., McCammon, J., Schloesser, R. J., Zhou, R., Du, J. et al. (2008). BAG1 plays a critical role in regulating recovery from both manic-like and depression-like behavioral impairments. Proc. Natl. Acad. Sci. USA 105, 8766-8771. (Pubitemid 351987754)
67. Maier, S. F. (1984). Learned helplessness and animal models of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 8, 435-446. (Pubitemid 14051222)
68. Malatynska, E., Goldenberg, R., Shuck, L., Haque, A., Zamecki, P., Crites, G., Schindler, N. and Knapp, R. J. (2002). Reduction of submissive behavior in rats: a test for antidepressant drug activity. Pharmacology 64, 8-17. (Pubitemid 33151608)
69. Manev, H. and Uz, T. (2006). Clock genes: influencing and being influenced by psychoactive drugs. Trends Pharmacol. Sci. 27, 186-189.
70. Manji, H. K., Moore, G. J. and Chen, G. (2000). Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J. Clin. Psychiatry 61 Suppl. 9, 82-96.
71. Manji, H. K., Gottesman, II and Gould, T. D. (2003). Signal transduction and genes-tobehaviors pathways in psychiatric diseases. Sci. STKE 2003, pe49.
72. Mansour, H. A., Monk, T. H. and Nimgaonkar, V. L. (2005). Circadian genes and bipolar disorder. Ann. Med. 37, 196-205.
73. McKinney, W. T., Jr and Bunney, W. E., Jr (1969). Animal model of depression. I. Review of evidence: implications for research. Arch. Gen. Psychiatry 21, 240-248.
74. McQueen, M. B., Devlin, B., Faraone, S. V., Nimgaonkar, V. L., Sklar, P., Smoller, J. W., Abou Jamra, R., Albus, M., Bacanu, S. A., Baron, M. et al. (2005). Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am. J. Hum. Genet. 77, 582-595. (Pubitemid 41361605)
75. Miczek, K. A. and O'Donnell, J. M. (1978). Intruder-evoked aggression in isolated and nonisolated mice: effects of psychomotor stimulants and L-dopa. Psychopharmacology (Berl. ) 57, 47-55.
76. Munakata, K., Tanaka, M., Mori, K., Washizuka, S., Yoneda, M., Tajima, O., Akiyama, T., Nanko, S., Kunugi, H., Tadokoro, K. et al. (2004). Mitochondrial DNA 3644T->C mutation associated with bipolar disorder. Genomics 84, 1041-1050. (Pubitemid 39469129)
77. O'Donnell, K. C. and Gould, T. D. (2007). The behavioral actions of lithium in rodent models: leads to develop novel therapeutics. Neurosci. Biobehav. Rev. 31, 932-962.
78. Ogden, C. A., Rich, M. E., Schork, N. J., Paulus, M. P., Geyer, M. A., Lohr, J. B., Kuczenski, R. and Niculescu, A. B. (2004). Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol. Psychiatry 9, 1007-1029. (Pubitemid 39524290)
79. Porsolt, R. D., Le Pichon, M. and Jalfre, M. (1977). Depression: a new animal model sensitive to antidepressant treatments. Nature 266, 730-732. (Pubitemid 8073804)
80. Porsolt, R. D., Chermat, R., Lenegre, A., Avril, I., Janvier, S. and Steru, L. (1987). Use of the automated tail suspension test for the primary screening of psychotropic agents. Arch. Int. Pharmacodyn. Ther. 288, 11-30. (Pubitemid 17134783)
81. Prickaerts, J., Moechars, D., Cryns, K., Lenaerts, I., van Craenendonck, H., Goris, I., Daneels, G., Bouwknecht, J. A. and Steckler, T. (2006). Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J. Neurosci. 26, 9022-9029. (Pubitemid 44319393)
82. Quiroz, J. A., Gray, N. A., Kato, T. and Manji, H. K. (2008). Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 33, 2551-2565.
83. Roybal, K., Theobold, D., Graham, A., DiNieri, J. A., Russo, S. J., Krishnan, V., Chakravarty, S., Peevey, J., Oehrlein, N., Birnbaum, S. et al. (2007). Mania-like behavior induced by disruption of CLOCK. Proc. Natl. Acad. Sci. USA 104, 6406-6411. (Pubitemid 47186107)
84. Ryan, G. P. and Boisse, N. R. (1983). Experimental induction of benzodiazepine tolerance and physical dependence. J. Pharmacol. Exp. Ther. 226, 100-107.
85. Schloesser, R. J., Song, J., Klein, P. S. and Manji, H. K. (2008). Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 33, 110-133.
86. Schneikert, J., Hubner, S., Martin, E. and Cato, A. C. (1999). A nuclear action of the eukaryotic cochaperone RAP46 in downregulation of glucocorticoid receptor activity. J. Cell Biol. 146, 929-940. (Pubitemid 29430437)
87. Schulze, T. G., Buervenich, S., Badner, J. A., Steele, C. J., Detera-Wadleigh, S. D., Dick, D., Foroud, T., Cox, N. J., MacKinnon, D. F., Potash, J. B. et al. (2004). Loci on chromosomes 6q and 6p interact to increase susceptibility to bipolar affective disorder in the national institute of mental health genetics initiative pedigrees. Biol. Psychiatry 56, 18-23. (Pubitemid 38813401)
88. Shacka, J. J. and Roth, K. A. (2005). Regulation of neuronal cell death and neurodegeneration by members of the Bcl-2 family: therapeutic implications. Curr. Drug Targets CNS Neurol. Disord. 4, 25-39.
89. Shaltiel, G., Maeng, S., Malkesman, O., Pearson, B., Schloesser, R. J., Tragon, T., Rogawski, M., Gasior, M., Luckenbaugh, D., Chen, G. et al. (2008). Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania. Mol. Psychiatry 13, 858-872.
90. Sherwin, C. M. (1998). Voluntary wheel running: a review and novel interpretation. Anim. Behav. 56, 11-27.
91. Sklar, P., Gabriel, S. B., McInnis, M. G., Bennett, P., Lim, Y. M., Tsan, G., Schaffner, S., Kirov, G., Jones, I., Owen, M. et al. (2002). Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol. Psychiatry 7, 579-593. (Pubitemid 34888421)
92. Stork, C. and Renshaw, P. E. (2005). Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol. Psychiatry 10, 900-919. (Pubitemid 41486483)
93. Svenningsson, P., Chergui, K., Rachleff, I., Flajolet, M., Zhang, X., El Yacoubi, M., Vaugeois, J. M., Nomikos, G. G. and Greengard, P. (2006). Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 311, 77-80. (Pubitemid 43063061)
94. Washizuka, S., Iwamoto, K., Kazuno, A. A., Kakiuchi, C., Mori, K., Kametani, M., Yamada, K., Kunugi, H., Tajima, O., Akiyama, T. et al. (2004). Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder in Japanese and the National Institute of Mental Health pedigrees. Biol. Psychiatry 56, 483-489. (Pubitemid 39278245)
95. Wei, E. (1973). Assessment of precipitated abstinence in morphine- dependent rats. Psychopharmacologia 28, 35-44.
96. Wei, Q., Lu, X. Y., Liu, L., Schafer, G., Shieh, K. R., Burke, S., Robinson, T. E., Watson, S. J., Seasholtz, A. F. and Akil, H. (2004). Glucocorticoid receptor overexpression in forebrain: a mouse model of increased emotional lability. Proc. Natl. Acad. Sci. USA 101, 11851-11856. (Pubitemid 39095383)
97. Westberry, J. M., Sadosky, P. W., Hubler, T. R., Gross, K. L. and Scammell, J. G. (2006). Glucocorticoid resistance in squirrel monkeys results from a combination of a transcriptionally incompetent glucocorticoid receptor and overexpression of the glucocorticoid receptor co-chaperone FKBP51. J. Steroid Biochem. Mol. Biol. 100, 34-41.
98. Willner, P. (1984). The validity of animal models of depression. Psychopharmacol. Bull. 83, 1-16.
99. Willner, P. (1986). Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case. Prog. Neuropsychopharmacol. Biol. Psychiatry 10, 677-690.
100. Willner, P. (1991). Animal models as simulations of depression. Trends Pharmacol. Sci. 12, 131-136.
101. Willner, P., Muscat, R. and Papp, M. (1992). An animal model of anhedonia. Clin. Neuropharmacol. 15 Suppl. 1 Pt A, 550A-551A.
102. Willour, V. L., Chen, H., Toolan, J., Belmonte, P., Cutler, D. J., Goes, F. S., Zandi, P., Lee, R. S., MacKinnon, D. F., Mondimore, F. M. et al. (2009). Family-based association of FKBP5 in bipolar disorder. Mol. Psychiatry 14, 261-268.
103. Xu, H., Steven Richardson, J. and Li, X. M. (2003). Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus. Neuropsychopharmacology 28, 53-62.
104. Young, J. W., Minassian, A., Paulus, M. P., Geyer, M. A. and Perry, W. (2007). A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor. Neurosci. Biobehav. Rev. 31, 882-896. (Pubitemid 47285352)
105. Zhou, R., Gray, N. A., Yuan, P., Li, X., Chen, J., Chen, G., Damschroder-Williams, P., Du, J., Zhang, L. and Manji, H. K. (2005). The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers. J. Neurosci. 25, 4493-4502. (Pubitemid 40629139)